Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

May 6, 2022

Study Completion Date

May 6, 2022

Conditions

Asthma

Interventions

DRUG

Tiotropium Bromide

respimat inhaler 2.5mcg/puff

DRUG

Matching placebo

matching placebo Respimat inhaler

Trial Locations (1)

Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall, Saskatoon

All Listed Sponsors

lead

University of Saskatchewan

OTHER

NCT05113615 - Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma | Biotech Hunter | Biotech Hunter